227 related articles for article (PubMed ID: 1525324)
1. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.
Colditz GA; Stampfer MJ; Willett WC; Hunter DJ; Manson JE; Hennekens CH; Rosner BA; Speizer FE
Cancer Causes Control; 1992 Sep; 3(5):433-9. PubMed ID: 1525324
[TBL] [Abstract][Full Text] [Related]
2. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
3. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Beral V; Reeves G; Bull D; Green J;
J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
[TBL] [Abstract][Full Text] [Related]
6. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
8. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
9. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
11. Unopposed estrogen therapy and the risk of invasive breast cancer.
Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.
Kirsh V; Kreiger N
Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women.
Colditz GA; Stampfer MJ; Willett WC; Hennekens CH; Rosner B; Speizer FE
JAMA; 1990 Nov; 264(20):2648-53. PubMed ID: 2232041
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
16. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.
Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Bogdan G; Willett WC
Am J Epidemiol; 1995 Oct; 142(8):788-95. PubMed ID: 7572954
[TBL] [Abstract][Full Text] [Related]
17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
19. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of postmenopausal hormone use and ovarian cancer risk.
Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
